ArticleBritish journal of pharmacology2009

Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism.

Ronald Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.